New drug aims to boost immune system against two cancers before surgery
NCT ID NCT06129604
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 25 times
Summary
This study tests a drug called TPST-1495 in 10 people with endometrial or colorectal cancer who are scheduled for surgery. The drug targets specific receptors to help the immune system fight cancer. Researchers will check blood and tumor samples before and after treatment to see if the drug works and how it affects the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CARCINOMA (EC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
OU Health Stephenson Cancer Center
Oklahoma City, Oklahoma, 73117, United States
Conditions
Explore the condition pages connected to this study.